๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Neurodevelopmental outcome of infants with acute lymphoblastic leukemia : A Children's Cancer Group Report

โœ Scribed by Thomas A. Kaleita; Gregory H. Reaman; William E. MacLean; Harland N. Sather; J. Kenneth Whitt


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
81 KB
Volume
85
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


The authors are thankful to a parent whose financial support provided much assistance in achieving the very high rate of follow-up neurodevelopmental evaluations. They also acknowledge the following individuals for their special efforts in locating children and helping to arrange a significant number of these evaluations:


๐Ÿ“œ SIMILAR VOLUMES


Prognostic significance of cytogenetic a
โœ Nyla A. Heerema; Harland N. Sather; Martha G. Sensel; Mei K. Lee; Raymond Hutchi ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 124 KB ๐Ÿ‘ 2 views

## Background: The authors have determined the prognostic significance of cytogenetically detectable 12p abnormalities, which are frequent in children with acute lymphoblastic leukemia (all), in a large cohort of patients treated on risk-adjusted protocols of the children's cancer group (ccg). ##

Improvement in CNS protective treatment
โœ Tsurusawa, Masahito; Katano, Naoyuki; Yamamoto, Yoshifumi; Hirota, Takahisa; Koi ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 126 KB ๐Ÿ‘ 2 views

Background. Prevention of central nervous system (CNS) leukemia by early introduction of therapy to this sanctuary site is an essential component of modern treatment strategy for acute lymphoblastic leukemia (ALL). However, the optimal form of preventive CNS therapy remains debatable. Procedure. To

Clinical significance of Philadelphia ch
โœ Fatih M. Uckun; James B. Nachman; Harland N. Sather; Martha G. Sensel; Peter Kra ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 136 KB ๐Ÿ‘ 2 views

## BACKGROUND. Children with Philadelphia (Ph) chromosome positive ( ฯฉ ) acute lymphoblastic leukemia (ALL) represent a subgroup at very high risk for treatment failure. In this report, the authors assessed the outcome of Ph ฯฉ ALL in a large cohort of children treated on contemporary intensive che